Quick Research
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Cell Line
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Iran
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 27,713 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
β-hydroxybutyrate, a ketone body, suppresses tumor growth, stemness, and invasive phenotypes in non-small cell lung cancer (2025-06-22)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: NCI-H1975 Cells Line, PC-9 Cells Line -
A comparison of cell death pathways in three different kinds of human lung cancer cell lines following hematoporphyrin derivative-mediated photodynamic therapy (2025-08-02)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: NCI-H446 Cells Line, NCI-H520 Cells Line, BEAS-2B Cells Line -
Potential therapeutic GSK-3β inhibitor 9-ING-41 is active in combination with venetoclax in double-hit lymphoma (DHL) (2025-11-11)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: RPMI-1640 Medium -
Nuclear translocation of Cx43 promotes to CRC progression and associates with β-catenin accumulation (2025-12-07)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: Human Umbilical Vein Endothelial Cells, Human Aortic Smooth Muscle Cells -
CD44v5 enhances the IL-4/IL-4Rα/STAT6/SAM68 aix inducing M2 polarization and promoting triple-negative breast cancer progression (2025-11-30)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: MDA-MB-468 Cells Line, THP-1 Cells Line -
NCAPD2 promotes the progression of lung adenocarcinoma through an AKT/MDM2/E2F1 positive feedback loop (2025-11-30)
Journal: CANCER BIOLOGY & THERAPY (2025) IF: 4.6Products Cited: STR Identification -
Co-Infection by Porphyromonas gingivalis and Fusobacterium nucleatum Increases PD-L1 Expression in Esophageal Cancer Tissues (2025-08-11)
-
Dual efficacy of tocilizumab in managing PD-1 inhibitors-induced myocardial inflammatory injury and suppressing tumor growth with PD-1 inhibitors: a preclinical study (2025-01-03)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 4.6Products Cited: LLC [LL/2; LLC1] Cells Line, RAW 264.7 Cells Line -
Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy (2025-02-04)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 4.6Products Cited: CMT-64 Cells Line, LLC-LUC Cells Line -
Machine learning-derived prognostic signature integrating programmed cell death and mitochondrial function in renal clear cell carcinoma: identification of PIF1 as a novel target (2025-02-25)
Journal: CANCER IMMUNOLOGY IMMUNOTHERAPY (2025) IF: 4.6Products Cited: Caki-1 Cells Line, OS-RC-2 Cells Line, A-498 Cells Line
